BOB体育

Skip to main content
(352) 733-0111

Clinical trials

Our exceptional foundation of physicians and state-of-the-art methods, like XVIVO and intensity-modulated radiation therapy, to diagnose and treat complex lung diseases makes pulmonology care a hallmark of BOB体育.

Interstitial lung disease team
  • Sapphire

    This study aims to evaluate the efficacy and safety of inhaled treprostinil in subjects with sarcoidosis-associated interstitial lung disease and pulmonary hypertension.

    Investigator
    Ali Ataya
    Ages
    18 Years - 99 Years
    Sexes
    All
  • 1305-0014 (FIBRONEERTM IPF)

    This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older. If they already take nintedanib or pirfenidone for their IPF, they can continue treatment鈥�

    Investigators
    Christopher Harden, Divya C Patel
    Ages
    40 Years - N/A
    Sexes
    All
  • 1305-0023 (FIBRONEERTM ILD)

    This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic Pulmonary Fibrosis (IPF) can join the study. If they already take nintedanib, they can continue鈥�

    Investigators
    Christopher Harden, Divya C Patel
    Ages
    18 Years - N/A
    Sexes
    All